217 related articles for article (PubMed ID: 34952595)
1. Prognostic significance of natural killer cell-associated markers in gastric cancer: quantitative analysis using multiplex immunohistochemistry.
Na HY; Park Y; Nam SK; Koh J; Kwak Y; Ahn SH; Park DJ; Kim HH; Lee KS; Lee HS
J Transl Med; 2021 Dec; 19(1):529. PubMed ID: 34952595
[TBL] [Abstract][Full Text] [Related]
2. Impaired natural killer cell responses are associated with loss of the highly activated NKG2A(+)CD57(+)CD56(dim) subset in HIV-1 subtype D infection in Uganda.
Naluyima P; Eller MA; Laeyendecker O; Quinn TC; Serwadda D; Sewankambo NK; Gray RH; Michael NL; Wabwire-Mangen F; Robb ML; Sandberg JK
AIDS; 2014 Jun; 28(9):1273-8. PubMed ID: 24959961
[TBL] [Abstract][Full Text] [Related]
3. Reduced Expression of Siglec-7, NKG2A, and CD57 on Terminally Differentiated CD56
Zulu MZ; Naidoo KK; Mncube Z; Jaggernath M; Goulder PJR; Ndung'u T; Altfeld M; Thobakgale CF
AIDS Res Hum Retroviruses; 2017 Dec; 33(12):1205-1213. PubMed ID: 28810810
[TBL] [Abstract][Full Text] [Related]
4. Regulation of Adaptive NK Cells and CD8 T Cells by HLA-C Correlates with Allogeneic Hematopoietic Cell Transplantation and with Cytomegalovirus Reactivation.
Horowitz A; Guethlein LA; Nemat-Gorgani N; Norman PJ; Cooley S; Miller JS; Parham P
J Immunol; 2015 Nov; 195(9):4524-36. PubMed ID: 26416275
[TBL] [Abstract][Full Text] [Related]
5. The increase of CD57+ T cells in the peripheral blood and their impaired immune functions in patients with advanced gastric cancer.
Chochi K; Ichikura T; Majima T; Kawabata T; Matsumoto A; Sugasawa H; Kawarabayashi N; Takayama E; Hiraide H; Seki S; Mochizuki H
Oncol Rep; 2003; 10(5):1443-8. PubMed ID: 12883721
[TBL] [Abstract][Full Text] [Related]
6. Human Leukocyte Antigen-G Inhibits the Anti-Tumor Effect of Natural Killer Cells via Immunoglobulin-Like Transcript 2 in Gastric Cancer.
Wan R; Wang ZW; Li H; Peng XD; Liu GY; Ou JM; Cheng AQ
Cell Physiol Biochem; 2017; 44(5):1828-1841. PubMed ID: 29224003
[TBL] [Abstract][Full Text] [Related]
7. Analysis of NK cell clones obtained using interleukin-2 and gene-modified K562 cells revealed the ability of "senescent" NK cells to lose CD57 expression and start expressing NKG2A.
Streltsova MA; Erokhina SA; Kanevskiy LM; Lee DA; Telford WG; Sapozhnikov AM; Kovalenko EI
PLoS One; 2018; 13(12):e0208469. PubMed ID: 30517188
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of NK receptors CD94 and NKG2A by T cells in rheumatoid arthritis patients in remission compared to active disease.
Walsh CE; Ryan EJ; O'Farrelly C; Golden-Mason L; FitzGerald O; Veale DJ; Bresnihan B; Fearon U
PLoS One; 2011; 6(11):e27182. PubMed ID: 22102879
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of CD57(+) T lymphocytes in the peripheral blood of patients with advanced gastric cancer.
Akagi J; Baba H
Int J Clin Oncol; 2008 Dec; 13(6):528-35. PubMed ID: 19093181
[TBL] [Abstract][Full Text] [Related]
10. Prognostic implication of CD57, CD16, and TGF-β expression in oral squamous cell carcinoma.
Taghavi N; Bagheri S; Akbarzadeh A
J Oral Pathol Med; 2016 Jan; 45(1):58-62. PubMed ID: 25808210
[TBL] [Abstract][Full Text] [Related]
11. Systematic characterization of human CD8+ T cells with natural killer cell markers in comparison with natural killer cells and normal CD8+ T cells.
Ohkawa T; Seki S; Dobashi H; Koike Y; Habu Y; Ami K; Hiraide H; Sekine I
Immunology; 2001 Jul; 103(3):281-90. PubMed ID: 11454057
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of HLA-E Expression Combined with Natural Killer Cell Status as a Prognostic Factor for Advanced Gastric Cancer.
Morinaga T; Iwatsuki M; Yamashita K; Matsumoto C; Harada K; Kurashige J; Iwagami S; Baba Y; Yoshida N; Komohara Y; Baba H
Ann Surg Oncol; 2022 Aug; 29(8):4951-4960. PubMed ID: 35412205
[TBL] [Abstract][Full Text] [Related]
13. Expansion of a unique CD57⁺NKG2Chi natural killer cell subset during acute human cytomegalovirus infection.
Lopez-Vergès S; Milush JM; Schwartz BS; Pando MJ; Jarjoura J; York VA; Houchins JP; Miller S; Kang SM; Norris PJ; Nixon DF; Lanier LL
Proc Natl Acad Sci U S A; 2011 Sep; 108(36):14725-32. PubMed ID: 21825173
[TBL] [Abstract][Full Text] [Related]
14. Dynamic Alteration in HLA-E Expression and Soluble HLA-E via Interaction with Natural Killer Cells in Gastric Cancer.
Morinaga T; Iwatsuki M; Yamashita K; Yasuda-Yoshihara N; Yamane T; Matsumoto C; Harada K; Eto K; Kurashige J; Ishimoto T; Baba Y; Miyamoto Y; Yoshida N; Baba H
Ann Surg Oncol; 2023 Feb; 30(2):1240-1252. PubMed ID: 36149610
[TBL] [Abstract][Full Text] [Related]
15. Repopulation of circulating T, B and NK lymphocytes following bone marrow and blood stem cell transplantation.
Parrado A; Casares S; Prieto J; Carmona M; Vaquero A; Rodríguez-Fernández JM
Hematol Cell Ther; 1997 Dec; 39(6):301-6. PubMed ID: 9497889
[TBL] [Abstract][Full Text] [Related]
16. NKG2A Expression Is Not
Mahaweni NM; Ehlers FAI; Sarkar S; Janssen JWH; Tilanus MGJ; Bos GMJ; Wieten L
Front Immunol; 2018; 9():1415. PubMed ID: 29988376
[TBL] [Abstract][Full Text] [Related]
17. Blocking the natural killer cell inhibitory receptor NKG2A increases activity of human natural killer cells and clears hepatitis B virus infection in mice.
Li F; Wei H; Wei H; Gao Y; Xu L; Yin W; Sun R; Tian Z
Gastroenterology; 2013 Feb; 144(2):392-401. PubMed ID: 23103614
[TBL] [Abstract][Full Text] [Related]
18. Human cytomegalovirus-induced NKG2C(hi) CD57(hi) natural killer cells are effectors dependent on humoral antiviral immunity.
Wu Z; Sinzger C; Frascaroli G; Reichel J; Bayer C; Wang L; Schirmbeck R; Mertens T
J Virol; 2013 Jul; 87(13):7717-25. PubMed ID: 23637420
[TBL] [Abstract][Full Text] [Related]
19. Exploring NK cell receptor dynamics in paediatric leukaemias: implications for immunotherapy and prognosis.
Tu C; Buckle I; Leal Rojas I; Rossi GR; Sester DP; Moore AS; Radford K; Guillerey C; Souza-Fonseca-Guimaraes F
Clin Transl Immunology; 2024; 13(3):e1501. PubMed ID: 38525380
[TBL] [Abstract][Full Text] [Related]
20. Assay of T- and NK-cell subsets and the expression of NKG2A and NKG2D in patients with new-onset systemic lupus erythematosus.
Li WX; Pan HF; Hu JL; Wang CZ; Zhang N; Li J; Li XP; Xu JH; Ye DQ
Clin Rheumatol; 2010 Mar; 29(3):315-23. PubMed ID: 20012119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
